DEVELOPMENT AND EVALUATION OF A PATIENT INFORMATION LEAFLET FOR TYPE 2 DIABETES MELLITUS PATIENTS
DOI:
https://doi.org/10.22159/ajpcr.2026v19i2.57285Keywords:
Patient information leaflets, Type 2 diabetes mellitus, Patient counseling, Readability.Abstract
Objectives: This study aimed to develop and evaluate the patient information leaflets (PILs) for type 2 diabetes mellitus (T2DM) patients.
Methods: The PILs were prepared in English by referring to primary, secondary, and tertiary resources. Readability of the PIL was assessed using the Flesch reading ease (FRE) test, Flesch–Kincaid grade level (FKGL), and user readability methods. User opinion on PILs content and design was obtained from T2DM patients (n=40). The Baker Able Leaflet Design (BALD) method was used to assess the layout and design characteristics of the PILs.
Results: The FRE and FKGL readability scores were 62.9 and 6.6, respectively. The BALD criteria scores for English and Nepali PILs were 29 and 25, respectively. The overall user testing readability mean scores were significantly improved from 47.5 to 97.25. 90% of T2DM patients rated the PILs as good design and content. Most of them were housewife female patients (mean age 57.725) with a primary level of education and belonged to the upper-lower class of socioeconomic status.
Conclusion: The developed PILs met the standard criteria for easy reading and comprehension. The majority of them had a good opinion on the content and design of the PILs.
Downloads
References
1. Dhakal G, Prasad Malla K, Malla B. Correlation of serum urea, creatinine and urinary microalbumin in type 2 diabetic patients in western, Nepal: A cross sectional study. Int J Heal Sci Res. 2023;13(3):11-7. doi: 10.52403/ijhsr.20230303
2. Dhyani S, Butola M, Sautha V, Jakhmola V. Resent advances in treatment approaches for diabetes mellitus and related complications: A review. Int J Appl Pharm. 2025;17(2):12-30.
3. Kumari KV, Fatima MK, Sultana F, Chakradhar T, Quadri MM. A study to evaluate the effect of empagliflozin on cardiovascular and renal outcomes of patients woth type 2 diabetes mellitus at a tertiary care hospital in Telengana. Int J Pharm Pharm Sci. 2025;17(3):10-5.
4. Tripathy JP. Burden and risk factors of diabetes and hyperglycemia in India: Findings from the global burden of disease study 2016. Diabetes Metab Syndr Obes. 2018;11:381-7. doi: 10.2147/DMSO.S157376, PMID 30104893
5. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843, PMID 31518657
6. Abouammoh NA, Alshamrani MA. Knowledge about diabetes and glycemic control among diabetic patients in Saudi Arabia. J Diabetes Res. 2020;2020:1239735. doi: 10.1155/2020/1239735, PMID 32215269
7. Hening WN, Sartika RA, Sauriasari R. Effect of hospital pharmacist counseling on clinical outcomes of type 2 diabetes mellitus outpatients. J Res Pharm Pract. 2019;8(3):155-61. doi: 10.4103/jrpp.JRPP_19_67, PMID 31728347
8. Kumah E, Afriyie EK, Abuosi AA, Ankomah SE, Fusheini A, Otchere G. Influence of the model of care on the outcomes of diabetes self-management education program: A scoping review. J Diabetes Res. 2021;2021:2969243. doi: 10.1155/2021/2969243, PMID 33688505
9. Wang W, Geng L, Sun C, Li H, Wang J. Efficacy of pharmaceutical care in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial. Int J Clin Pract. 2022;2022:7681404. doi: 10.1155/2022/7681404, PMID 35685555
10. Shrestha N, Karki K, Poudyal A, Aryal KK, Mahato NK, Gautam N, et al. Prevalence of diabetes mellitus and associated risk factors in Nepal: Findings from a nationwide population-based survey. BMJOpen. 2022;12(2):e060750. doi: 10.1136/bmjopen-2022-060750, PMID 35193925
11. Pardhan S, Upadhyaya T, Smith L, Sharma T, Tuladhar S, Adhikari B, et al. Individual patient-centered target-driven intervention to improve clinical outcomes of diabetes, health literacy, and self-care practices in Nepal: A randomized controlled trial. Front Endocrinol. 2023;14:1076253. doi: 10.3389/fendo.2023.1076253, PMID 36742401
12. Wahyuni AS, Marwa D, Oktasari SR, Yulianti T, Nugraheni AY, AL-Samea RA. Determination of factors affecting medication adherence in type 2 diabetes mellitus patients in a tertiary hospital: Case-control study. Int J App Pharm. 2025;17(2):126-31. doi: 10.22159/ijap.2025.v17s2.20
13. Sahoo J, Mohanty S, Kundu A, Epari V. Medication adherence among patients of type II diabetes mellitus and its associated risk factors: A cross-sectional study in a tertiary care hospital of eastern India. Cureus. 2022;14(12):e33074. doi: 10.7759/cureus.33074, PMID 36721541
14. Rajpurohit S, Musunuri B, Mohan PB, Vani LR, Bhat G, Shetty S. Development and evaluation of patient information leaflet for liver cirrhosis patients. Clin Epidemiol Glob Heal. 2023;24:101436. doi: 10.1016/j.cegh.2023.101436
15. Sekhar MS, Mk U, Vyas N, Rodrigues GS. Development and evaluation of patient information leaflet for diabetic foot ulcer patients. Int J Endocrinol Metab. 2017;15(3):e55454. doi: 10.5812/ijem.55454, PMID 29201075
16. Joshi SK, Acharya K. Modification of Kuppuswamy’s socioeconomic status scale in the context of Nepal, 2019. Kathmandu Univ Med J (KUMJ). 2019;17(65):1-2. PMID 31734669
17. Mateti UV, Nagappa AN, Attur RP, Bairy M, Nagaraju SP, Mallayasamy S, et al. Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients. Saudi Pharm J. 2015;23(6):621-5. doi: 10.1016/j.jsps.2015.01.022, PMID 26702256
18. UpToDate. Available from: https://www.uptodate.com/ contents/initial-management-of-hyperglycemia/in/adults/with/ typediabetesmellitus?search=dm%20type%202&source=search_ result&selectedtitle=1%7e150&usage_type=default&display_rank=1 [Last accessed on 2025 Jan 30].
19. Available from: https://emedicine.medscape.com/ article/117853overview?&icd=login_success_email_match_fpf [Last accessed on 2025 Jan 30].
20. WebMD. Available from: https://www.webmd.com/ search?query=diabetes+mellitus+type+2 [Last accessed on 2025 Jan 30].
21. Elizabeth A, Hackett SNJ. Jackson. Diabetes mellitus. In: Walker R, Whittlesea C, editors. Clinical Pharmacy and Therapeutics. 5th ed. London: Elsevier Limited; 2012. p. 685-708.
22. Gilbert GE, Prion S. Making sense of methods and measurement: Lawshe’s content validity index. Clin Simul Nurs. 2016;12(12):530-1. doi: 10.1016/j.ecns.2016.08.002
23. Le NK, Turnbull N, Van Dam C, Khiewkhern S, Thiabrithi S. Impact of knowledge, attitude, and practices of Type 2 diabetic patients: A study in the locality in Vietnam. J Educ Health Promot. 2021;10:72. doi: 10.4103/jehp.jehp_712_20, PMID 34084819
24. Poojari PG, Pai K, Khan SA, Shenoy S, Bhandary PV, Shetty S, et al. Development, validation, user testing of patient information leaflet to improve awareness of metabolic side effects in patients on atypical antipsychotics. Clin Epidemiol Glob Heal. 2024;29:101763. doi: 10.1016/j.cegh.2024.101763
25. Good Calculators. Available from: https://goodcalculators.com/flesch-kincaid-calculator [Last accessed on 2025 Jan 30].
26. Vinay BC, Shastry CS, Kodangala S, Mateti UV, Bhat K. Development and validation of patient information leaflet for coronary heart disease patients. Perspect Clin Res. 2021;12(2):83-6. doi: 10.4103/picr. PICR_58_19, PMID 34012904
27. Sirimalla S, Mateti UV, Shenoy P, Shetty S. Health education for chronic kidney disease patients not on dialysis through the pictorial patient information leaflet. J Pharm Technol. 2023;39(6):274-80. doi: 10.1177/87551225231198988, PMID 37974594
28. Van Beusekom MM, Grootens-Wiegers P, Bos MJ, Guchelaar HJ, Van Den Broek JM. Low literacy and written drug information: Information-seeking, leaflet evaluation and preferences, and roles for images. Int J Clin Pharm. 2016;38(6):1372-9. doi: 10.1007/s11096-016-0376-4, PMID 27655308
29. Renuka P, Pushpanjali K. Leaflet preparation and validation procedures. Univ J Public Heal. 2013;1(3):110-4. doi: 10.13189/ujph.2013.010310
30. Nandakumar UP, Joel JJ, Shetty J, Shastry CS, Krishna Bhat CH. Preparation, validation and user-testing of patient information leaflet on cancer. Pharm Hosp Clin. 2021;56(1):12-7. doi: 10.1016/j. phclin.2020.07.012
31. Vooradi S, D Acharya L, Seshadri S, Thunga G, Vijayanarayana K. Preparation, validation and user-testing of patient information leaflets on diabetes and hypertension. Indian J Pharm Sci. 2018;80(1):118-25. doi: 10.4172/pharmaceutical-sciences.1000336
Published
How to Cite
Issue
Section
Copyright (c) 2025 Bindu Malla, Tirtha Lal Upadhyaya, Neha Sharma
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.